PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
November 23, 2025Scientific Reports20 citationsOpen Access

Morphology dependent antibacterial activity of zinc oxide nanoparticles against clinically relevant bacteria

View Full Paper
NZNaila ZubairRARasha Mohammed Sajet Al-OqailiASAisha Siddique

Key Points

Key points are not available for this paper at this time.

Abstract

The present study focuses on the antibacterial activity of ZnO nanoparticles, evaluating variations based on morphology. Interest in ZnO nanoparticles arises from their high surface-to-volume ratio that enables effective interaction with bacterial cells. Their antibacterial properties depend on size and nanostructure, with enhanced activity attributed to increased surface area, promoting maximum contact with microbial membranes, cellular damage, and growth inhibition. Zinc oxide (ZnO) nanoparticles with two distinct shapes-ellipsoidal nanorods (Z1) and 3D microspheres (Z2)-were synthesized using a simple, template-free aqueous precipitation method. Zinc nitrate and hexamethylenetetramine (HMT) served as starting materials. The nanoparticles were characterized using scanning electron microscopy (SEM), X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FT-IR), and thermogravimetric analysis (TGA). The point of zero charge (PZC) was determined by the salt addition method. SEM images showed that particle shape changed with reaction time. XRD confirmed a hexagonal wurtzite crystal structure, with average crystallite sizes of 22.09 nm for Z1 and 27.18 nm for Z2. FT-IR spectra showed Zn-O bond vibrations between 540 and 411 cm-1. Antibacterial activity was evaluated using the agar well diffusion method against Gram-positive (Streptococcus mutans, Staphylococcus aureus) and Gram-negative (Escherichia coli, Enterobacter cloacae) bacteria. The synthesized ZnO nanoparticles exhibited significantly higher antibacterial effects than commercial ZnO, which showed no activity at tested concentrations (0.25, 0.50, and 0.75 µg/µL). At 0.75 µg/µL, Z1 nanorods produced inhibition zones of 30 mm (E. coli), 28 mm (E. cloacae), 28 mm (S. mutans), and 30 mm (S. aureus). Z2 microspheres showed even stronger effects: 35 mm, 32 mm, 30 mm, and 31 mm, respectively. These findings demonstrate the superior antibacterial properties of the synthesized ZnO nanoparticles, particularly the 3D microspheres, highlighting their potential in antimicrobial coatings and biomedical applications.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zubair et al. (2025) studied this question.

synapsesocial.com/papers/69403fa32d562116f290e507https://doi.org/10.1038/s41598-025-29075-2
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Morphology dependent antibacterial activity of zinc oxide nanoparticles against clinically relevant bacteria2025
  2. 2Antibacterial Activity, Cell Wall Damage, and Cytotoxicity of Zinc Oxide Nanospheres, Nanorods, and Nanoflowers2024 · 29 citations
  3. 3Optimizing Antimicrobial Efficacy: Investigating the Impact of Zinc Oxide Nanoparticle Shape and Size2024 · 51 citations
  4. 4Structural and Morphological Insights of ZnO Nanoparticles and their Antibacterial Applications2026
  5. 5Tailoring Size Distribution and Morphology by Exploring ZnO Nanoparticle Synthesis Methods Toward Cell Viability With Improved Antibacterial Efficacy2026